Do Khanh Nam, Duong Phuong Thi, Phung Toi Lam, Duong Yen Thi, Hoang Giang Truong, Le Huong Thi
Department of Nutrition and Food Safety, School of Preventive Medicine and Public Health, Hanoi Medical University, Hanoi, Vietnam.
Department of Nutrition and Dietetics, Hanoi Medical University Hospital, Hanoi Medical University, Hanoi, Vietnam.
Int J Endocrinol Metab. 2024 Jun 26;22(2):e146358. doi: 10.5812/ijem-146358. eCollection 2024 Apr.
Hypocalcemia is the most frequent complication of thyroid surgeries. Hypocalcemia is the most common complication following thyroid surgeries and is crucial in managing patients with thyroid cancer.
This study aimed to describe hypocalcemia after thyroidectomy and evaluate the factors associated with postoperative hypocalcemia.
A cross-sectional study was conducted on 91 patients with thyroid cancer at Hanoi Medical University Hospital. Hypocalcemia was defined as serum calcium levels lower than 2.1 mmol/L, measured 24 hours after surgery.
In the postoperative period, 27.5% of the patients exhibited hypocalcemia, with distinct prevalence rates observed between the total thyroidectomy group (47.6%) and the thyroid lobectomy group (10.2%). Concurrently, hypoparathyroidism manifested in 15.4% of the cases. Various factors were identified as contributors to postoperative hypocalcemia, including lymph node metastasis (odds ratio [OR] = 2.6; P < 0.05), total thyroidectomy (OR = 8.0; P < 0.01), diminished parathyroid hormone (PTH) levels (OR = 12.6; P < 0.001), and reduced 25-hydroxyvitamin D3 (25[OH]D3) levels (P < 0.01). Furthermore, multivariate analyses revealed that free thyroxine (FT4) (P = 0.04), 25(OH)D3 (P = 0.037), surgical procedure (P < 0.001), and cancer stage (P < 0.001) independently predicted postoperative hypocalcemia. Notably, our findings underscored a substantial correlation between total thyroidectomy (OR = 21.5, P < 0.001), diminished PTH levels (P < 0.001), and the occurrence of postoperative hypoparathyroidism.
The identification of lymph node metastasis, total thyroid surgery, decreased PTH and 25(OH)D3 levels, and albumin concentration are crucial factors in guiding the surgical team to prevent the onset of hypocalcemia.
低钙血症是甲状腺手术最常见的并发症。低钙血症是甲状腺手术后最常见的并发症,对甲状腺癌患者的管理至关重要。
本研究旨在描述甲状腺切除术后的低钙血症,并评估与术后低钙血症相关的因素。
对河内医科大学医院的91例甲状腺癌患者进行了一项横断面研究。低钙血症定义为术后24小时测得的血清钙水平低于2.1 mmol/L。
术后,27.5%的患者出现低钙血症,全甲状腺切除组(47.6%)和甲状腺叶切除组(10.2%)的患病率明显不同。同时,15.4%的病例出现甲状旁腺功能减退。多种因素被确定为术后低钙血症的促成因素,包括淋巴结转移(比值比[OR]=2.6;P<0.05)、全甲状腺切除术(OR=8.0;P<0.01)、甲状旁腺激素(PTH)水平降低(OR=12.6;P<0.001)和25-羟基维生素D3(25[OH]D3)水平降低(P<0.01)。此外,多因素分析显示游离甲状腺素(FT4)(P=0.04)、25(OH)D3(P=0.037)、手术方式(P<0.001)和癌症分期(P<0.001)独立预测术后低钙血症。值得注意的是,我们的研究结果强调了全甲状腺切除术(OR=21.5,P<0.001)、PTH水平降低(P<0.001)与术后甲状旁腺功能减退发生之间的显著相关性。
识别淋巴结转移、全甲状腺手术、PTH和25(OH)D3水平降低以及白蛋白浓度是指导手术团队预防低钙血症发生的关键因素。